A randomised controlled trial of triple antiplatelet therapy (Aspirin, Clopidogrel and Dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility
Background: Aspirin, dipyridamole and clopidogrel are effective in secondary vascular prevention. Combination therapy with three antiplatelet agents might maximise the benefit of antiplatelet treatment in the secondary prevention of ischaemic stroke. Methodology/Principal Findings: A randomised,...
| Main Authors: | Sprigg, Nikola, Gray, Laura J., England, Timothy J., Wilmot, Marc R., Zhao, Lian, Sare, Gillian M., Bath, Philip M.W. |
|---|---|
| Format: | Article |
| Published: |
2008
|
| Online Access: | https://eprints.nottingham.ac.uk/948/ |
Similar Items
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
by: Bath, Philip M.W., et al.
Published: (2018)
by: Bath, Philip M.W., et al.
Published: (2018)
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
by: Sacco, Ralph L., et al.
Published: (2008)
by: Sacco, Ralph L., et al.
Published: (2008)
Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke
by: Zhao, Lian, et al.
Published: (2006)
by: Zhao, Lian, et al.
Published: (2006)
Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk
by: Halkes, P.H.A., et al.
Published: (2008)
by: Halkes, P.H.A., et al.
Published: (2008)
Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
by: Bath, Philip M.W., et al.
Published: (2015)
by: Bath, Philip M.W., et al.
Published: (2015)
The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Amin, Arwa M., et al.
Published: (2017)
by: Amin, Arwa M., et al.
Published: (2017)
Characteristics and outcomes of patients with or without a bleeding event: results from the triple antiplatelets for reducing dependency in ischaemic stroke (TARDIS) trial
by: Woodhouse, Lisa J., et al.
Published: (2018)
by: Woodhouse, Lisa J., et al.
Published: (2018)
Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel and prasugrel, and bleeding disorders
by: Bath, Philip M.W., et al.
Published: (2018)
by: Bath, Philip M.W., et al.
Published: (2018)
Baseline characteristics of the 3,096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial
by: Bath, Philip M.W., et al.
Published: (2017)
by: Bath, Philip M.W., et al.
Published: (2017)
Antiplatelet activity should be measured routinely: no
by: Bath, Philip M.W.
Published: (2009)
by: Bath, Philip M.W.
Published: (2009)
Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders
by: Bath, Philip M., et al.
Published: (2018)
by: Bath, Philip M., et al.
Published: (2018)
Impact of atrial fibrillation diagnosis or carotid enderterectomy requirement on outcome in patients from the triple antiplatelets for reducing dependency after ischaemic stroke (TARDIS) trial
by: Woodhouse, Lisa J., et al.
Published: (2018)
by: Woodhouse, Lisa J., et al.
Published: (2018)
The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
by: Mostafa, Arwa Mohamed Amin
Published: (2016)
by: Mostafa, Arwa Mohamed Amin
Published: (2016)
Is there a link between aspirin therapy and stroke severity
by: Bath, Philip M.W.
Published: (2007)
by: Bath, Philip M.W.
Published: (2007)
Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
by: Beridze, M., et al.
Published: (2015)
by: Beridze, M., et al.
Published: (2015)
Antiplatelet therapy following ischaemic stroke: continue or change pre-existing therapy?
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)
Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke
by: Gray, Laura J., et al.
Published: (2006)
by: Gray, Laura J., et al.
Published: (2006)
High blood pressure in acute stroke: to treat or not to treat
by: Sare, Gillian M., et al.
Published: (2007)
by: Sare, Gillian M., et al.
Published: (2007)
Control of blood pressure after stroke
by: Bath, Philip M.W., et al.
Published: (2006)
by: Bath, Philip M.W., et al.
Published: (2006)
Speeding stroke recovery? A systematic review of amphetamine after stroke
by: Sprigg, Nikola, et al.
Published: (2009)
by: Sprigg, Nikola, et al.
Published: (2009)
Thigh-length compression stockings and DVT after stroke
by: Bath, Philip M.W., et al.
Published: (2009)
by: Bath, Philip M.W., et al.
Published: (2009)
Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets
by: Hilkens, Nina A., et al.
Published: (2017)
by: Hilkens, Nina A., et al.
Published: (2017)
The prevalence of co-administration of clopidogrel and proton pump inhibitors
by: Shrestha, Kajal, et al.
Published: (2011)
by: Shrestha, Kajal, et al.
Published: (2011)
Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA Collaboration
by: Sare, Gillian M., et al.
Published: (2009)
by: Sare, Gillian M., et al.
Published: (2009)
Twisted Aspirin Crystals
by: Cui, X., et al.
Published: (2013)
by: Cui, X., et al.
Published: (2013)
Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333)
by: Sprigg, Nikola, et al.
Published: (2007)
by: Sprigg, Nikola, et al.
Published: (2007)
Granulocyte-colony stimulating factor (G-CSF) for stroke: an individual patient data meta-analysis
by: England, Timothy J., et al.
Published: (2016)
by: England, Timothy J., et al.
Published: (2016)
Serum amyloid protein is associated with outcome following acute ischaemic stroke: data from the REmote ischaemic Conditioning After Stroke Trial (RECAST)
by: Appleton, Jason P., et al.
Published: (2018)
by: Appleton, Jason P., et al.
Published: (2018)
Current state and novel approaches of antiplatelet therapy
by: Metharom, P., et al.
Published: (2015)
by: Metharom, P., et al.
Published: (2015)
Systematic reviews as a tool for planning and
interpreting trials
by: Bath, Philip M.W., et al.
Published: (2009)
by: Bath, Philip M.W., et al.
Published: (2009)
Association between hormone replacement therapy and subsequent stroke: a meta analysis
by: Bath, Philip M.W., et al.
Published: (2005)
by: Bath, Philip M.W., et al.
Published: (2005)
The relationship between baseline blood pressure and
computed tomography findings in acute stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)
by: Sare, Gillian M., et al.
Published: (2009)
by: Sare, Gillian M., et al.
Published: (2009)
Stem cells for enhancing recovery after stroke: a review
by: England, Timothy J., et al.
Published: (2009)
by: England, Timothy J., et al.
Published: (2009)
The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research
by: Bath, Philip M.W., et al.
Published: (2016)
by: Bath, Philip M.W., et al.
Published: (2016)
Blood pressure management in acute stroke
by: Appleton, Jason P., et al.
Published: (2016)
by: Appleton, Jason P., et al.
Published: (2016)
Therapeutic potential of transdermal glyceryl trinitrate in the management of acute stroke
by: Appleton, Jason P., et al.
Published: (2016)
by: Appleton, Jason P., et al.
Published: (2016)
Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.
by: Yudi, M., et al.
Published: (2016)
by: Yudi, M., et al.
Published: (2016)
Simple Synthetic Receptors for Aspirin
by: Nguyen, Thanh Vinh, et al.
Published: (2014)
by: Nguyen, Thanh Vinh, et al.
Published: (2014)
Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
by: Hilkens, Nina A., et al.
Published: (2018)
by: Hilkens, Nina A., et al.
Published: (2018)
Remote Ischaemic Conditioning after Stroke Trial (RECAST): a pilot randomised placebo controlled phase II trial in acute ischaemic stroke (ISRCTN 86672015)
by: England, Timothy J., et al.
Published: (2017)
by: England, Timothy J., et al.
Published: (2017)
Similar Items
-
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
by: Bath, Philip M.W., et al.
Published: (2018) -
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
by: Sacco, Ralph L., et al.
Published: (2008) -
Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke
by: Zhao, Lian, et al.
Published: (2006) -
Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk
by: Halkes, P.H.A., et al.
Published: (2008) -
Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
by: Bath, Philip M.W., et al.
Published: (2015)